-
Biomedical
-
Early Cancer Screening
-
China and US Markets
LAMH
-
Gambecom® DNA Test
-
IvyGene®Plus
-
Gambecom®plus - Liver Cancer Gene Methylation Assay
-
Top 7 High Incidence and Lethality Cancer Tests
-
Customer Profile
LAMH (Laboratory for Advanced Medicine & Health Group) is an AI-driven early cancer screening and diagnostics innovator co-founded by international business leaders, top scientists and authoritative doctors with the idea of ‘making early cancer screening earlier, more accurate, more accessible and easier’. ‘LAMH is the world's first and only early cancer screening and diagnostics company with a fully integrated R&D, manufacturing, approval, lab and commercialisation operation in the two largest economies in the world, China and the US.
-
Informatics Challenges
1.Internationalised platform to meet the integrated management of Chinese and American markets;
2.Laboratory Lims docking;
3.GSP/GMP management requirements;
4.Production management and batch traceability;
5.Multi-dimensional accounting system requirements.
-
Solutions
1. The international and group nature of NetSuite platform naturally meets LAMH's demand for international and integrated management; personalised management of subsidiaries, automated management of transactions and consolidated reports;
2.Systematically synchronise core information such as orders, labour cost, lab inventory, order reports, etc. by connecting with Lims;
3.Satisfy GXP's management demands through NetSuite system, full life cycle batch traceability management of materials, semi-finished products and finished products;
4.Production management: work order receipt, transfer, tail material back to the warehouse and three waste disposal; refined cost accounting: completion of inventory and BOM roll-up, end of the month overheads apportionment;
5.According to the demands of various departments and management business and financial analysis, increase the auxiliary accounting items directly reflected in the management report.